Harris Bell-temin PhD

Harris Bell-Temin is a scientific leader dedicated to turning complex proteomic data into actionable insights that advance drug discovery. Over the past 15+ years, he has built and led high-performing, multi-site teams that deliver transformative results in target identification, target validation, therapeutic optimization, and biomarker discovery. Harris currently serves as Director of Proteomics at Johnson & Johnson and holds a PhD from the University of South Florida.